Search research articles
Contact Us
Filters
Showing results (461-470 of 488) with videos related to
Page
of 49
Sort By:
Studies in Mycology
|
May 26, 2021
<i>Aspergillus fumigatus</i> and aspergillosis: From basics to clinics
A Arastehfar, A Carvalho, J Houbraken, et al.
Leukemia
|
January 30, 2023
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia
Christine E Ryan, Danielle M Brander, Paul M Barr, et al.
Leukemia & Lymphoma
|
February 21, 2024
Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP
Ronald Nemec, Marielle Scherrer-Crosbie, Jeremy S Abramson, et al.
American Journal of Hematology
|
December 29, 2020
Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses
Jennifer R Brown, Sarah R Walker, Lisa N Heppler, et al.
British Journal of Haematology
|
June 26, 2013
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
Philippe Armand, Yasuhiro Oki, Donna S Neuberg, et al.
Blood
|
June 15, 2023
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, et al.
Blood
|
December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium
Mark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
Plos Pathogens
|
June 20, 2014
Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes
Tobias Schwarzmüller, Biao Ma, Ekkehard Hiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
Ian W Flinn, Carole B Miller, Kirit M Ardeshna, et al.
Blood
|
March 19, 2020
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
Gaurav Goyal, Mark L Heaney, Matthew Collin, et al.
Page
of 49
Search research articles
Search
Showing results (461-470 of 488) with videos related to
Sort By:
Page
of 49
Studies in Mycology
|
May 26, 2021
<i>Aspergillus fumigatus</i> and aspergillosis: From basics to clinics
A Arastehfar, A Carvalho, J Houbraken, et al.
Leukemia
|
January 30, 2023
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia
Christine E Ryan, Danielle M Brander, Paul M Barr, et al.
Leukemia & Lymphoma
|
February 21, 2024
Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP
Ronald Nemec, Marielle Scherrer-Crosbie, Jeremy S Abramson, et al.
American Journal of Hematology
|
December 29, 2020
Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses
Jennifer R Brown, Sarah R Walker, Lisa N Heppler, et al.
British Journal of Haematology
|
June 26, 2013
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
Philippe Armand, Yasuhiro Oki, Donna S Neuberg, et al.
Blood
|
June 15, 2023
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, et al.
Blood
|
December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium
Mark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
Plos Pathogens
|
June 20, 2014
Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes
Tobias Schwarzmüller, Biao Ma, Ekkehard Hiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma
Ian W Flinn, Carole B Miller, Kirit M Ardeshna, et al.
Blood
|
March 19, 2020
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
Gaurav Goyal, Mark L Heaney, Matthew Collin, et al.
Page
of 49